arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2502.18531cs.AIcs.CLcs.LG
收藏

提升肝病临床试验效率:一种安全的、基于大语言模型的预筛选流程

Enhancing Hepatopathy Clinical Trial Efficiency: A Secure, Large Language Model-Powered Pre-Screening Pipeline

The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine(广西中医药大学第一附属医院);Institute of Biointellgence Technology, BGI Research(华大研究院生物智能技术研究所);Guangdong Bigdata Engineering Technology Research Center for Life Sciences, BGI Research(华大研究院广东省生命科学大数据工程技术研究中心)

Xiongbin Gui, Hanlin Lv, Xiao Wang, Longting Lv, Yi Xiao, Lei Wang

AI总结:

本文提出了一种基于大语言模型的安全预筛选流程,通过两种策略提升肝病临床试验的效率与精度。

摘要:

背景:涉及复杂肝病(如肝细胞癌和肝硬化)的队列招募往往需要解释语义复杂的标准。传统手动筛选方法耗时且易出错。虽然AI赋能的预筛选提供了潜在解决方案,但仍然存在关于准确率、效率和数据隐私方面的挑战。方法:我们开发了一种新的患者预筛选流程,该流程利用临床专业知识来指导大语言模型的精确、安全和高效应用。该流程将复杂标准分解为一系列复合问题,然后通过电子健康记录进行语义问题回答,采用两种策略:(1)路径A,拟人化专家的思维链策略;(2)路径B,预设立场在代理协作中的策略,特别是在处理复杂临床推理场景时。该流程在三个关键指标上进行了评估——精度、时间消耗和反事实推断——在问题和标准层面。结果:我们的流程在标准层面实现了高精度(0.921)和高效(每个任务0.44秒)。路径B在复杂推理中表现突出,而路径A在精确数据提取中有效且处理时间更短。两种路径的精度相当。该流程在肝细胞癌试验(0.878)和肝硬化试验(0.843)中表现出色。结论:这种数据安全且时间高效的流程在肝病试验中表现出高精度,为优化临床试验流程提供了有前景的解决方案。其效率和适应性使其适合提高患者招募。其在资源有限环境中的能力进一步增强了其在临床应用中的实用性。

英文摘要:

Background: Recruitment for cohorts involving complex liver diseases, such as hepatocellular carcinoma and liver cirrhosis, often requires interpreting semantically complex criteria. Traditional manual screening methods are time-consuming and prone to errors. While AI-powered pre-screening offers potential solutions, challenges remain regarding accuracy, efficiency, and data privacy. Methods: We developed a novel patient pre-screening pipeline that leverages clinical expertise to guide the precise, safe, and efficient application of large language models. The pipeline breaks down complex criteria into a series of composite questions and then employs two strategies to perform semantic question-answering through electronic health records - (1) Pathway A, Anthropomorphized Experts' Chain of Thought strategy, and (2) Pathway B, Preset Stances within an Agent Collaboration strategy, particularly in managing complex clinical reasoning scenarios. The pipeline is evaluated on three key metrics-precision, time consumption, and counterfactual inference - at both the question and criterion levels. Results: Our pipeline achieved high precision (0.921, in criteria level) and efficiency (0.44s per task). Pathway B excelled in complex reasoning, while Pathway A was effective in precise data extraction with faster processing times. Both pathways achieved comparable precision. The pipeline showed promising results in hepatocellular carcinoma (0.878) and cirrhosis trials (0.843). Conclusions: This data-secure and time-efficient pipeline shows high precision in hepatopathy trials, providing promising solutions for streamlining clinical trial workflows. Its efficiency and adaptability make it suitable for improving patient recruitment. And its capability to function in resource-constrained environments further enhances its utility in clinical settings.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑